Publication

Byline

Singapore Clinical Trial: A Multinational, Multicenter, Prospective, Randomized, Controlled, Open-Label, Phase 3 Study of Lutetium-177 (177Lu) Rosopatamab Tetraxetan in Combination with Standard of Care Versus Standard of Care Alone in Patients with Prostate-Specific Membrane Antigen (PSMA) Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) after Androgen Receptor Pathway Inhibitor (ARPI) Treatment

Singapore, May 22 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter, Prospective, Randomized, Controlled, Open-Label, Phase 3 Study of Lut... और पढ़ें


Singapore Clinical Trial: CO45042: A Phase III, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Divarasib Plus Pembrolizumab Versus Pembrolizumab And Pemetrexed And Carboplatin or Cisplatin in Patients with Previously Untreated, KRAS G12C-Mutated, Advanced Or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Singapore, May 22 -- The Health Sciences Authority received information related to the study titled 'CO45042: A Phase III, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Divarasib ... और पढ़ें


Singapore Clinical Trial: A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Compared with Investigator’s Choice of Chemotherapy (Paclitaxel, Nab-paclitaxel or Gemcitabine + Carboplatin) in Combination With Pembrolizumab in Patients with PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Singapore, May 22 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durv... और पढ़ें


Singapore Clinical Trial: TulmiSTAR-01: A two-part, Phase I dose escalation and expansion followed by a randomized, open-label multicenter, Phase II study to assess the safety and efficacy of the combination of tulmimetostat (DZR123) and JSB462 (luxdegalutamide) vs standard of care in patients with progressive metastatic castrate resistant prostate cancer

Singapore, May 22 -- The Health Sciences Authority received information related to the study titled 'TulmiSTAR-01: A two-part, Phase I dose escalation and expansion followed by a randomized, open-labe... और पढ़ें


Singapore Clinical Trial: A Master Protocol of an Open-Label, Multi-Drug, Multi-Centre, Phase II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumour Activity of Novel Combinations in Participants with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (LIBRA)

Singapore, May 22 -- The Health Sciences Authority received information related to the study titled 'A Master Protocol of an Open-Label, Multi-Drug, Multi-Centre, Phase II Study to Evaluate the Safety... और पढ़ें


Google AI Search is eating the web and publishers are panicking

India, May 22 -- Once upon a time, Google searched for and returned a list of URLs. Now, it will be a machine that answers questions. Through AI mode and AI summaries, Google is asking us to ask longe... और पढ़ें


Matthew Stafford Contract Extension Explained: Los Angeles Rams Star Eyes Historic $500M NFL Milestone Ahead of Aaron Rodgers And Tom Brady

India, May 22 -- NFL money talks louder than ever, and Matthew Stafford is now at the center of it. Fresh off what's being called the first MVP season of his 17-year career, the Los Angeles Rams have ... और पढ़ें


कर्क राशिफल 22 मई 2026: आज धन भाव के केतु कराएंगे लाभ या हानि? पढ़ें विस्तृत भविष्यफल

नई दिल्ली, मई 22 -- Today Cancer Horoscope 23 May 2026, आज का कर्क राशिफल: आज कर्क राशि वालों के लिए दिन अच्छा रहने वाला है। आपकी मानसिक स्थिति बहुत अच्छी चल रही है और आपका यह मानसिक स्वास्थ्य आपकी व्... और पढ़ें


Pakistan name squad for Australia ODIsPublished on: May 22, 2026 10:00 PM

Pakistan, May 22 -- Pakistan have announced a 16-member squad for the upcoming three-match ODI series against Australia. Star batter Babar Azam returns to the side after missing the Bangladesh tour du... और पढ़ें


LG Sinha vows to protect youth

JAMMU, May 22 -- Lieutenant Governor Manoj Sinha on Thursday said that drugs and terrorism are "two sides of the same coin" in Jammu and Kashmir, asserting that investigations have revealed direct lin... और पढ़ें